| [1] |
Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, et al. 2019. Applications of machine learning in drug discovery and development. |
| [2] |
Yang H, Sun L, Wang Z, Li W, Liu G, et al. 2018. ADMETopt: a web server for ADMET optimization in drug design via scaffold hopping. |
| [3] |
Torng W, Altman RB. 2019. Graph convolutional neural networks for predicting drug-target interactions. |
| [4] |
Olivecrona M, Blaschke T, Engkvist O, Chen H. 2017. Molecular de-novo design through deep reinforcement learning. |
| [5] |
Cui H, Wang C, Maan H, Pang K, Luo F, et al. 2024. scGPT: toward building a foundation model for single-cell multi-omics using generative AI. |
| [6] |
Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, et al. 2015. Discovery and resupply of pharmacologically active plant-derived natural products: A review. |
| [7] |
Li S, Xiao W. 2025. General expert consensus on the application of network pharmacology in the research and development of new traditional Chinese medicine drugs. |
| [8] |
Chen YH, Bi JH, Xie M, Zhang H, Shi ZQ, et al. 2021. Classification-based strategies to simplify complex traditional Chinese medicine (TCM) researches through liquid chromatography-mass spectrometry in the last decade (2011-2020): Theory, technical route and difficulty. |
| [9] |
Patti GJ, Yanes O, Siuzdak G. 2012. Innovation: Metabolomics: the apogee of the omics trilogy. |
| [10] |
Wang Y, Zhao J, Xu Y, Tao C, Tong J, et al. 2023. Uncovering SOD3 and GPX4 as new targets of Benzo[α]pyrene-induced hepatotoxicity through Metabolomics and Chemical Proteomics. |
| [11] |
Gong P, Cui N, Wu L, Liang Y, Hao K, et al. 2012. Chemicalome and metabolome matching approach to elucidating biological metabolic networks of complex mixtures. |
| [12] |
Zheng X, Cai X, Hao H. 2022. Emerging targetome and signalome landscape of gut microbial metabolites. |
| [13] |
Zhao MY, Chen YH, Wang WY, Sun WP, Xiao HH, et al. 2022. A strategy to comprehensively analyze the bioactivity of complex herbal prescriptions via peak-by-peak cutting and knock-out chromatography: Qiliqiangxin capsule as an example. |
| [14] |
Liu FT, Chen YH, Wang WY, Zhang JN, Sun RB, et al. 2025. A comprehensive analysis of volatile and nonvolatile components in berberis fortunei and its inhibition against HT29 colorectal cancer cells through GC-IMS, LC-QTOF-MS, and docking-based network analysis. |
| [15] |
Yang F, Liang Z, Zhao H, Zheng J, Liu L, et al. 2025. Mass spectral database-based methodologies for the annotation and discovery of natural products. |
| [16] |
Wang M, Carver JJ, Phelan VV, Sanchez LM, Garg N, et al. 2016. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. |
| [17] |
Yan Z, Ning J, Luo Z, Li D, Wang H, et al. 2025. Systematic analysis of the chemical components of gentiana urnula harry sm using SIRIUS and liquid chromatography high-resolution mass spectrometry. |
| [18] |
Wei JN, Belanger D, Adams RP, Sculley D. 2019. Rapid prediction of electron-ionization mass spectrometry using neural networks. |
| [19] |
Stravs MA, Dührkop K, Böcker S, Zamboni N. 2022. MSNovelist: de novo structure generation from mass spectra. |
| [20] |
Jiang M, Sha Y, Zou Y, Xu X, Ding M, et al. 2025. Integration of deep neural network modeling and LC-MS-based pseudo-targeted metabolomics to discriminate easily confused ginseng species. |
| [21] |
Wang H, Zhang L, Li X, Sun M, Jiang M, et al. 2024. Machine learning prediction for constructing a universal multidimensional information library of Panax saponins (ginsenosides). |
| [22] |
Mi N, Cheng T, Li H, Yang P, Mu X, et al. 2019. Metabolite profiling of traditional Chinese medicine formula Dan Zhi Tablet: An integrated strategy based on UPLC-QTOF/MS combined with multivariate statistical analysis. |
| [23] |
Chen Z, Lin Z, Wan H, Li C, Jin W, et al. 2025. Rapid and accurate metabolite identification of traditional Chinese medicine based on UPLC-Q-TOF-MS coupled with UNIFI analysis platform and quantitative structure-retention relationship: Danshen-Honghua herbal pair as an example. |
| [24] |
Li Y, Liu X, Zhou J, Li F, Wang Y, et al. 2025. Artificial intelligence in traditional Chinese medicine: advances in multi-metabolite multi-target interaction modeling. |
| [25] |
Feinberg EN, Joshi E, Pande VS, Cheng AC. 2020. Improvement in ADMET prediction with multitask deep featurization. |
| [26] |
Zhang X, Liu T, Fan X, Ai N. 2017. In silico modeling on ADME properties of natural products: Classification models for blood-brain barrier permeability, its application to traditional Chinese medicine and in vitro experimental validation. |
| [27] |
Daina A, Michielin O, Zoete V. 2017. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. |
| [28] |
Xiong G, Wu Z, Yi J, Fu L, Yang Z, et al. 2021. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. |
| [29] |
Chen L, Xia B, Wang Y, Huang X, Gu Y, et al. 2024. CMSSP: a contrastive mass spectra-structure pretraining model for metabolite identification. |
| [30] |
Li L, Wang X, Ma R, Hou M. 2024. An integrating strategy for systematic profiling of Chinese patent drug's chemicalome and associated metabolome: Huanghou antidiarrhea dropping pills as a case study. |
| [31] |
Zhu H, Chang W, Zhou C, Xu C, Su W, et al. 2021. Chemicalome and metabolome profiling of Chai-Gui Decoction using an integrated strategy based on UHPLC-Q-TOF-MS/MS analysis. |
| [32] |
Wang HY, Qu C, Li MN, Li CR, Liu RZ, et al. 2022. Time-series-dependent global data filtering strategy for mining and profiling of xenobiotic metabolites in a dynamic complex matrix: application to biotransformation of flavonoids in the extract of Ginkgo biloba by gut microbiota. |
| [33] |
Song HP, Chen J, Hong JY, Hao H, Qi LW, et al. 2015. A strategy for screening of high-quality enzyme inhibitors from herbal medicines based on ultrafiltration LC-MS and in silico molecular docking. |
| [34] |
Hao H, Kirchhoff F. 2025. Navigating drug discovery with targetome. |
| [35] |
Nguyen T, Le H, Quinn TP, Nguyen T, Le TD, et al. 2021. GraphDTA: predicting drug-target binding affinity with graph neural networks. |
| [36] |
Öztürk H, Özgür A, Ozkirimli E. 2018. DeepDTA: deep drug-target binding affinity prediction. |
| [37] |
Bai P, Miljković F, John B, Lu H. 2023. Interpretable bilinear attention network with domain adaptation improves drug–target prediction. |
| [38] |
Wu H, Liu J, Jiang T, Zou Q, Qi S, et al. 2024. AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism. |
| [39] |
Chen L, Tan X, Wang D, Zhong F, Liu X, et al. 2020. TransformerCPI: improving compound-protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments. |
| [40] |
Zhao Y, Xing Y, Zhang Y, Wang Y, Wan M, et al. 2025. Evidential deep learning-based drug-target interaction prediction. |
| [41] |
Paton AE, Boiko DA, Perkins JC, Cemalovic NI, Reschützegger T, et al. 2025. Connecting chemical and protein sequence space to predict biocatalytic reactions. |
| [42] |
Shah PM, Zhu H, Lu Z, Wang K, Tang J, et al. 2025. DeepDTAGen: a multitask deep learning framework for drug-target affinity prediction and target-aware drugs generation. |
| [43] |
Cao D, Chen M, Zhang R, Wang Z, Huang M, et al. 2025. SurfDock is a surface-informed diffusion generative model for reliable and accurate protein-ligand complex prediction. |
| [44] |
Namba S, Iwata M, Nureki SI, Yuyama Otani N, Yamanishi Y. 2025. Therapeutic target prediction for orphan diseases integrating genome-wide and transcriptome-wide association studies. |
| [45] |
Gonzalez G, Lin X, Herath I, Veselkov K, Bronstein M, et al. 2025. Combinatorial prediction of therapeutic perturbations using causally inspired neural networks. |
| [46] |
Zhang Y, Leung AK, Kang JJ, Sun Y, Wu G, et al. 2025. A multiscale functional map of somatic mutations in cancer integrating protein structure and network topology. |
| [47] |
Li J, Dan W, Zhang C, Liu N, Wang Y, et al. 2024. Exploration of berberine against ulcerative colitis via TLR4/NF-κB/HIF-1α pathway by bioinformatics and experimental validation. |
| [48] |
Kurzawa N, Leo IR, Stahl M, Kunold E, Becher I, et al. 2023. Deep thermal profiling for detection of functional proteoform groups. |
| [49] |
Leo IR, Kunold E, Audrey A, Tampere M, Eirich J, et al. 2025. Functional proteoform group deconvolution reveals a broader spectrum of ibrutinib off-targets. |
| [50] |
Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundbäck T, et al. 2014. The cellular thermal shift assay for evaluating drug target interactions in cells. |
| [51] |
Malinovska L, Cappelletti V, Kohler D, Piazza I, Tsai TH, et al. 2023. Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications. |
| [52] |
Piazza I, Beaton N, Bruderer R, Knobloch T, Barbisan C, et al. 2020. A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes. |
| [53] |
Luo P, Liu D, Zhang Q, Yang F, Wong YK, et al. 2022. Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1. |
| [54] |
Biggs GS, Cawood EE, Vuorinen A, McCarthy WJ, Wilders H, et al. 2025. Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomics. |
| [55] |
Peng W, Yang Y, Lu H, Shi H, Jiang L, et al. 2024. Network pharmacology combines machine learning, molecular simulation dynamics and experimental validation to explore the mechanism of acetylbinankadsurin A in the treatment of liver fibrosis. |
| [56] |
Edwards AM, Owen DR. 2025. Protein-ligand data at scale to support machine learning. |
| [57] |
Mayr F, Möller G, Garscha U, Fischer J, Rodríguez Castaño P, et al. 2020. Finding new molecular targets of familiar natural products using in silico target prediction. |
| [58] |
Zhong F, Wu X, Yang R, Li X, Wang D, et al. 2022. Drug target inference by mining transcriptional data using a novel graph convolutional network framework. |
| [59] |
Wang B, Pan B, Zhang T, Liu Q, Li S. 2025. Transfer learning and permutation-invariance improving predicting genome-wide, cell-specific and directional interventions effects of complex systems. |
| [60] |
Zhao WS, Chen KF, Liu M, Jia XL, Huang YQ, et al. 2023. Investigation of targets and anticancer mechanisms of covalently acting natural products by functional proteomics. |
| [61] |
Nie HJ, Fu YJ, Long S, Wang JY, Zhao WS, et al. 2025. Chemoproteomics reveals proteome-wide covalent and non-covalent targets of withaferin A. |
| [62] |
Wang C, Shi J, Rao Q, Shen B, Su C, et al. 2025. Obtain substance of anti-glioblastoma from Erigeron breviscapus through fragment-based target research (FBTR): An efficient strategy for pharmacology investigation and optimization of natural products. |
| [63] |
Zhou W, Gao Y. 2025. Phenotype–target coupled drug screening: a high-efficiency framework for innovative drug discovery from CHMs. |
| [64] |
Wang Y, Sui Y, Yao J, Jiang H, Tian Q, et al. 2024. Herb-CMap: a multimodal fusion framework for deciphering the mechanisms of action in traditional Chinese medicine using Suhuang antitussive capsule as a case study. |
| [65] |
Zhang L, Zheng Y, Shao M, Chen A, Liu M, et al. 2025. AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease. |
| [66] |
Guo F, Tang X, Zhang W, Wei J, Tang S, et al. 2020. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example. |
| [67] |
Liu K, Hong B, He ST, Du S, Ke J, et al. 2025. The potential mechanisms and material basis of Fuzheng Jiedu decoction broad-spectrum inhibiting coronaviruses. |
| [68] |
Yan D, Zheng Q, Chang K, Hua R, Liu Y, et al. 2025. Artificial intelligence in traditional Chinese medicine: from systems biological mechanism discovery, real-world clinical evidence inference to personalized clinical decision support. |
| [69] |
Zhang JN, Pei ZD, Wang WY, Zhao MY, Pei WH, et al. 2024. Integration of high-resolution LC-Q-TOF mass spectrometry and multidimensional chemical-biological analysis to detect nanomolar-level acetylcholinesterase inhibitors from different Parts of Zanthoxylum nitidum. |
| [70] |
Wang S, Fu JL, Hao HF, Jiao YN, Li PP, et al. 2021. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. |
| [71] |
Zhang R, Zhu X, Bai H, Ning K. 2019. Network pharmacology databases for traditional Chinese medicine: review and assessment. |
| [72] |
Vandereyken K, Sifrim A, Thienpont B, Voet T. 2023. Methods and applications for single-cell and spatial multi-omics. |
| [73] |
Liu J, Chen Y, Cao Z, Guan B, Peng J, et al. 2020. Babao Dan inhibits the migration and invasion of gastric cancer cells by suppressing epithelial-mesenchymal transition through the TGF-β/Smad pathway. |
| [74] |
Wang S, Zhao Y, Hu X. 2023. Exploring the mechanism of Suanzaoren decoction in treatment of insomnia based on network pharmacology and molecular docking. |
| [75] |
Song HP, Wu SQ, Hao H, Chen J, Lu J, et al. 2016. A chemical family-based strategy for uncovering hidden bioactive molecules and multicomponent interactions in herbal medicines. |
| [76] |
Zhang J, Li C, Zhang L, Heng Y, Wang S, et al. 2022. Andrographolide, a diterpene lactone from the Traditional Chinese Medicine Andrographis paniculate, induces senescence in human lung adenocarcinoma via p53/p21 and Skp2/p27. |
| [77] |
Yang L, Wang H, Zhu Z, Yang Y, Xiong Y, et al. 2025. Network pharmacology-driven sustainability: AI and multi-omics synergy for drug discovery in traditional Chinese medicine. |
| [78] |
Ren Z, Ren Y, Li Z, Xu H. 2024. TCMM: A unified database for traditional Chinese medicine modernization and therapeutic innovations. |
| [79] |
Li X, Ren J, Zhang W, Zhang Z, Yu J, et al. 2022. LTM-TCM: A comprehensive database for the linking of Traditional Chinese Medicine with modern medicine at molecular and phenotypic levels. |
| [80] |
Wei Q, Zhou Y, Hu Z, Shi Y, Ning Q, et al. 2024. Function-oriented mechanism discovery of coumarins from Psoralea corylifolia L. in the treatment of ovariectomy-induced osteoporosis based on multi-omics analysis. |
| [81] |
Yin YH, Li CH, Huang HP, Zhang C, Zhang SB, et al. 2024. A novel enzyme-based functional correlation algorithm for multi-omics reveals the potential mechanisms of traditional Chinese medicines: taking Jian-Pi-Yi-Shen formula as an example. |
| [82] |
Argelaguet R, Arnol D, Bredikhin D, Deloro Y, Velten B, et al. 2020. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. |
| [83] |
Patel-Murray NL, Adam M, Huynh N, Wassie BT, Milani P, et al. 2020. A multi-omics interpretable machine learning model reveals modes of action of small molecules. |
| [84] |
Zhou W, Yang K, Zeng J, Lai X, Wang X, et al. 2021. FordNet: Recommending traditional Chinese medicine formula via deep neural network integrating phenotype and molecule. |
| [85] |
Dong X, Zheng Y, Shu Z, Chang K, Xia J, et al. 2022. TCMPR: TCM prescription recommendation based on subnetwork term mapping and deep learning. |
| [86] |
Niu Q, Li H, Tong L, Liu S, Zong W, et al. 2023. TCMFP: a novel herbal formula prediction method based on network target's score integrated with semi-supervised learning genetic algorithms. |
| [87] |
Xue Z, Shang Y, Yang L, Li T, Yang B. 2025. A tailored database combining reference compound-derived metabolite, metabolism platform and chemical characteristic of Chinese herb followed by activity screening: application to magnoliae officinalis cortex. |
| [88] |
Zhang D, Zhang J, Chen S, Zhang H, Yang Y, et al. 2024. An integrated approach for studying exposure, metabolism, and disposition of traditional Chinese medicine using PATBS and MDRB tools: a case study of semen Armeniacae amarum. |
| [89] |
Zeng J, Jia X. 2025. Quantifying compatibility mechanisms in traditional Chinese medicine with interpretable graph neural networks. |
| [90] |
Qiao Y, Hu L, Zhang J, Hu P, Luo X. 2025. Identifying novel therapeutic targets of natural compounds in traditional Chinese medicine herbs with hypergraph representation learning. |
| [91] |
Wei W, Zeng Q, Wang Y, Guo X, Fan T, et al. 2023. Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. |
| [92] |
Khanal S, Kumar A, Kumar P, Thakur P, Chander AM, et al. 2025. Unraveling bioactive potential and production in Ganoderma lucidum through omics and machine learning modeling. |
| [93] |
Liu KX, Li N, Yin YH, Zhong ZJ, Li P, et al. 2022. An in-house database-driven untargeted identification strategy for deep profiling of chemicalome in Chinese medicinal formula. |
| [94] |
Tian Y, Wan N, Zhang H, Shao C, Ding M, et al. 2023. Chemoproteomic mapping of the glycolytic targetome in cancer cells. |
| [95] |
Zhou M, Wu B. 2025. Chinese medicine in regulating immune balance for the treatment of autoimmune diseases. |
| [96] |
Liu M, Wang Y, Deng W, Xie J, He Y, et al. 2024. Combining network pharmacology, machine learning, molecular docking and molecular dynamic to explore the mechanism of Chufeng Qingpi decoction in treating schistosomiasis. |
| [97] |
Chen J, Wei X, Zhang Q, Wu Y, Xia G, et al. 2023. The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms. |
| [98] |
Shang L, Wang Y, Li J, Zhou F, Xiao K, et al. 2023. Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation. |
| [99] |
Ma S, Liu J, Li W, Liu Y, Hui X, et al. 2023. Machine learning in TCM with natural products and molecules: current status and future perspectives. |
| [100] |
Gangwal A, Ansari A, Ahmad I, Azad AK, Kumarasamy V, et al. 2024. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities. |
| [101] |
Guo Q, Hernandez-Hernandez S, Ballester PJ. 2025. UMAP-based clustering split for rigorous evaluation of AI models for virtual screening on cancer cell lines. |
| [102] |
Vigil-Vásquez C, Schüller A. 2022. De novo prediction of drug targets and candidates by chemical similarity-guided network-based inference. |
| [103] |
Qadri YA, Shaikh S, Ahmad K, Choi I, Kim SW, et al. 2025. Explainable artificial intelligence: a perspective on drug discovery. |